Delivery Order SPE2DR25D2007-SPE2DR26FM12C
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $3,219.00 by the Defense Logistics Agency for 30-count tablets of Arimidex 1 mg. The award, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, was made under firm fixed-price terms with no set-aside designation, indicating the contract was competitively awarded. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $4,483.25 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count package) on November 3, 2025, with completion scheduled for November 4, 2025. This firm fixed-price delivery order represents a non-set-aside award and is performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award reflects AmerisourceBergen's role as a critical pharmaceutical distributor within the federal medical supply...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,378.10 for Arimidex 1 mg tablets (30-count packaging) with a completion date of November 14, 2025. This non-competitive, firm fixed-price delivery order was awarded on November 13, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor...
- The Defense Logistics Agency awarded a delivery order valued at $10,006.96 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30 count). This firm fixed-price delivery order, awarded on October 24, 2025, with an ultimate completion date of October 27, 2025, represents a direct pharmaceutical procurement supporting federal medical supply requirements. The award was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,215.65 to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Arimidex 1 mg tablets (30 count). The award is non-competitive and issued under a firm fixed-price delivery order contract type, with an ultimate completion date of November 17, 2025. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $5,789.34 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packages) on November 10, 2025, with completion scheduled for November 12, 2025. This firm fixed price, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $1,589.55 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count package) on November 12, 2025, with completion expected by November 13, 2025. This non-competitive, firm fixed-price delivery order was issued under a larger Indefinite Delivery Contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical supplier for...
- The Defense Logistics Agency awarded a $37,178.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) under contract 4570008790. The order, issued on November 14, 2025, with completion targeted for November 17, 2025, will be fulfilled from the contractor's facilities in Conshohocken, Pennsylvania. This non-set-aside award was competitively procured and represents a child delivery order under AmerisourceBergen's larger prime...
- The Defense Logistics Agency awarded a competitive delivery order valued at $11,825.31 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count) with an ultimate completion date of October 21, 2025. This non-set-aside contract represents a firm fixed-price delivery order under AmerisourceBergen's larger pharmaceutical supply agreement, with performance of work occurring at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a $5,438.88 delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) under a firm fixed price contract. The award, made on November 12, 2025, with an ultimate completion date of November 13, 2025, represents a non-competitive delivery order issued against AmerisourceBergen's larger pharmaceutical supply contract vehicle. The pharmaceutical will be delivered to the company's corporate office location in...
- SPE2DR25D2007Indefinite Delivery Contract
- SPE2DR25D2007-SPE2DR26FM12CDelivery Order
The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $3,074.40 for 30 tablets of Arimidex 1 mg, with performance in Conshohocken, Pennsylvania. This competitive, non-set-aside contract reflects firm fixed pricing and is scheduled for completion on November 13, 2025. The award represents a single delivery order executed under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for military and veteran healthcare systems. The company's comprehensive IDC with DLA enables it to supply pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support defense health programs globally. This specific delivery order for Arimidex, a hormone therapy medication, exemplifies the routine pharmaceutical procurement activities executed through the broader prime vendor contract vehicle, which supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 11/12/25 |